Welcome to LookChem.com Sign In|Join Free
  • or
Benzaldehyde, 4-(2-oxopropoxy)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

405228-13-9

Post Buying Request

405228-13-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

405228-13-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 405228-13-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,0,5,2,2 and 8 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 405228-13:
(8*4)+(7*0)+(6*5)+(5*2)+(4*2)+(3*8)+(2*1)+(1*3)=109
109 % 10 = 9
So 405228-13-9 is a valid CAS Registry Number.

405228-13-9Downstream Products

405228-13-9Relevant academic research and scientific papers

Silver-containing microemulsion as a high-efficient and recyclable catalytic system for hydration of alkynes

Dong, Qizhi,Li, Ningbo,Qiu, Renhua,Wang, Jinying,Guo, Cancheng,Xu, Xinhua

, p. 122 - 127 (2015)

A silver-catalyzed highly efficient and regioselective synthesis of ketones from a wide range of alkynes is described. The reaction is dramatically accelerated by its performance in aqueous emulsion, which is self-assembled by the addition of silver perfluorooctanesulfonate (1) and perfluorooctanesulfonic acid (PFOS) to water. The reaction is conducted under convenient conditions with broad substrate scope, including a variety of aromatic and aliphatic terminal alkynes and internal alkynes. Furthermore, the air- and light-stable silver catalytic microemulsion can be reused for 4 times with minimal change in catalytic efficiency.

INHIBITORS OF THE NOTCH TRANSCRIPTIONAL ACTIVATION COMPLEX AND METHODS FOR USE OF THE SAME

-

Paragraph 00138, (2016/10/11)

Disclosed herein are inhibitors of the Notch transcriptional activation complex, and methods for their use in treating or preventing diseases, such as cancer. The inhibitors described herein can include compounds of Formula (I) and pharmaceutically acceptable salts thereof: Formula (I), wherein the substituents are as described.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 405228-13-9